Affordable Access

deepdyve-link
Publisher Website

Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.

Authors
  • Dong, Tao-Tao1
  • Zhou, Hou-Min
  • Wang, Lin-Lin
  • Feng, Bo
  • Lv, Bo
  • Zheng, Min-Hua
  • 1 Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China. , (China)
Type
Published Article
Journal
Annals of Surgical Oncology
Publisher
Springer - Society of Surgical Oncology
Publication Date
Jun 01, 2011
Volume
18
Issue
6
Pages
1797–1804
Identifiers
DOI: 10.1245/s10434-011-1561-2
PMID: 21267784
Source
Medline
License
Unknown

Abstract

This study demonstrates the ability of salinomycin to selectively target "CD133+" cell subpopulations and decrease the malignant traits in colorectal cancer lines.

Report this publication

Statistics

Seen <100 times